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Verhoeven, Frank A., Ellis P. C. M. Moerings, Jos
M. J. Lamers, Georg Hennemann, Theo J. Visser, and
Maria E. Everts. Inhibitory effects of calcium channel block-
ers on thyroid hormone uptake in neonatal rat cardiomyo-
cytes. Am J Physiol Heart Circ Physiol 281: H1985–H1991,
2001.—The effects of the Ca21 channel blockers verapamil,
nifedipine, and diltiazem on triiodothyronine (T3) and thy-
roxine (T4) uptake were tested in cultured cardiomyocytes
from 2-day-old rats. Experiments were performed at 37°C in
medium with 0.5% BSA for [125I]T3 (100 pM) or 0.1% BSA for
[125I]T4 (350 pM). The 15-min uptake of [125I]T3 was 0.124 6
0.013 fmol/pM free T3 (n 5 6); [125I]T4 uptake was 0.032 6
0.003 fmol/pM free T4 (n 5 12). Neither T3 nor T4 uptake was
affected by 1% DMSO (diluent for nifedipine and verapamil).
Uptake of [125I]T3 but not of [125I]T4 was dose dependently
reduced by incubation with 1–100 mM verapamil (49–87%,
P , 0.05) or nifedipine (53–81%, P , 0.05). The relative
decline in [125I]T3 uptake after 4 h of incubation with 10 mM
verapamil or nifedipine was less than after 15 min or 1 h,
indicating that the major inhibitory effect of the Ca21 chan-
nel blockers occurred at the level of the plasma membrane.
The reduction of nuclear [125I]T3 binding by 10 mM verapamil
or nifedipine was proportional to the reduction of cellular
[125I]T3 uptake. Diltiazem (1–100 mM) had no dose-depen-
dent effect on [125I]T3 uptake but reduced [125I]T4 uptake by
45% (P , 0.05) at each concentration tested. Neither the
presence of 20 mM K1 nor the presence of low Ca21 in the
medium affected [125I]T3 uptake. In conclusion, the inhibi-
tory effects of Ca21 channel blockers on T3 uptake in cardi-
omyocytes are not secondary to their effects on Ca21 influx
but, rather, reflect interference with the putative T3 carrier
in the plasma membrane.
heart; culture; ATP; free hormone fraction
THYROID HORMONES induce a rise in cardiac output by
their chronotropic and inotropic effects (23, 31). When
thyroxine (T4) is used in replacement therapy for hy-
pothyroidism, this may induce myocardial ischemia
and lead to angina pectoris (1). More recently, it has
been shown that elevation of serum triiodothyronine
(T3) at hospital admission is associated with the devel-
opment and progression of acute myocardial ischemia
(22). Part of these effects may be secondary to the
profound influence of thyroid hormones on Ca21 han-
dling by the heart (5). In cardiomyocytes, 1) Ca21
uptake by (L-type) voltage-gated channels in the
plasma membrane is enhanced (14, 28), 2) Ca21 uptake
in the sarcoplasmic reticulum is accelerated (13, 18),
and 3) cellular Ca21 storage capacity is increased by
thyroid hormone (13, 18).
Ca21 channel blockers are widely used in the treat-
ment of angina pectoris and hypertension (19). Besides
those conventional applications, Ca21 channel blockers
have also been proposed as a supplement to T4 treat-
ment to control cardiac thyrotoxic symptoms (1, 17).
Ca21 channel blockers act by inhibiting the Ca21 influx
via the slow voltage-gated channels in the plasma
membrane, thus leading to reduced contractility of
vascular smooth muscle and the heart (19). This will
result in a lower blood pressure and a decrease in
myocardial oxygen consumption (5).
In myoblast (L6) cells, Topliss et al. (32) found that
the uptake of T3 was inhibited by organic Ca21 channel
blockers in a dose-dependent fashion (0.1–100 mM) as
follows: nifedipine . diltiazem . verapamil. In human
Hep G2 hepatoma cells, 10 mM nifedipine inhibited T3
uptake by ;80% (26). In neonatal cardiomyocytes, T3 is
taken up by an energy-dependent, carrier-mediated
mechanism that may be partly dependent on the Na1
gradient over the plasma membrane (10). For T4, how-
ever, such a mechanism could not be demonstrated,
although T4 enters the intracellular compartment of
the cardiomyocytes (10). In the perfused rat heart, T3
had a much more pronounced inotropic effect than T4
(27). Moreover, the same study showed that the inotro-
pic effects of T3 (1 nM–1 mM) could be blocked by
nifedipine and verapamil (10 nM–10 mM).
The present study was undertaken 1) to investigate
the effects of organic Ca21 channel blockers on the
uptake of T3 and T4 in cardiomyocytes and 2) to explore
the interaction between the uptake of thyroid hor-
mones and changes in intra- and extracellular Ca21
concentration. This was done by testing the effects of
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20 mM K1 and low Ca21 in the incubation medium on
T3 uptake. In our experiments we have used a repre-
sentative Ca21 channel blocker from each of the three
structurally distinct classes of compounds: verapamil
(a phenylalkylamine), nifedipine (a dihydropyridine),
and diltiazem (a benzothiazepine).
MATERIALS AND METHODS
Cell culture. Primary cultures of neonatal rat ventricular
myocytes were prepared as described in detail previously (2,
36) with some modifications (10, 33). Briefly, hearts removed
from 2-day-old Wistar rats were cut into small fragments and
dissociated with 0.1% trypsin for 10 min at 33°C. Cells from
the first treatment with trypsin were decanted and dis-
carded, and the remaining tissue was further digested with
fresh enzyme and decanted. DMEM with medium 199 (M199,
4:1), 5% FCS, 5% horse serum (HS), and 2% penicillin-
streptomycin (PS) was then added to the suspended cells.
This procedure was repeated seven times until most of the
tissue was dissociated. Deoxyribonuclease (20 U/ml) was
added, and the remaining tissue from the last step, together
with the trypsinized cells, was centrifuged (100 g) for 5 min.
The supernatant was discarded, and the cells were resus-
pended in 30 ml of DMEM-M199 with 5% FCS, 5% HS, and
2% PS. The cell suspension was passed through nylon mesh,
and the dispersed cells were preplated (2) into 250-ml culture
flasks for 60 min (37°C, 5% CO2) to remove fibroblasts. After
this procedure, the preparation consists of .90% of cardio-
myocytes (33). Cells of the enriched cardiomyocyte fraction
were plated into 48-well culture dishes at subconfluent den-
sity (5 3 105 cells/well) in 1-ml volumes of DMEM-M199 with
5% FCS, 5% HS, and 2% PS and, in some cases, at a density
of 106 cells/well in 2-ml volumes in 24-well culture dishes.
The cells were incubated in a humidified 5% CO2 atmo-
sphere at 37°C for 1 day. After 1 day the cells revealed
spontaneous and synchronous beating, and the medium was
replaced by fresh culture medium. Experiments were rou-
tinely performed after 5 days of culture.
Cellular uptake of [125I]T3 and [125I]T4. The incubation
medium was identical to the culture medium, except serum
was replaced by 0.5% bovine serum albumin (BSA) for mea-
surements of [125I]T3 uptake and by 0.1% BSA for [125I]T4
uptake (10). After removal of the culture medium, cells were
preincubated for 30 min at 37°C with 0.5 ml of medium
without or with 1–100 mM verapamil, nifedipine, or dilti-
azem and then incubated in 0.25 ml of medium for 15–240
min at 37°C without or with the same additions plus [125I]T3
(100,000 cpm, 100 pM) or [125I]T4 (200,000 cpm, 350 pM).
After incubation, the medium was removed and the cells
were washed with 1 ml of ice-cold saline to remove tracer not
bound to the cells. Cells were dissolved in 1 ml of 0.1 N NaOH
and counted for 125I activity in a 16-channel gamma counter
(model NE 1600, Nuclear Enterprises, Edinburgh, Scotland).
The amount of [125I]T3 or [125I]T4 taken up was expressed as
a percentage of the added radioactivity (percentage of the
dose). The same procedure was applied to incubations with-
out cells (blanks). All results were corrected for the radioac-
tivity recovered from the wells without cells.
To evaluate the effects of 20 mM K1 or low Ca21 on
[125I]T3 uptake, separate experiments were performed in
Krebs-Ringer (KR) buffer containing 139 mM NaCl, 4.2 mM
KCl, 1.5 mM CaCl2, 1.4 mM KH2PO4, 1.4 mM MgSO4, 5 mM
D-glucose, 25 mM tris(hydroxymethyl)aminomethane (Tris),
and 0.5% BSA (pH 7.4), where part of the NaCl (14.4 mM)
was replaced by an equimolar amount of KCl or where CaCl2
was omitted.
Nuclear [125I]T3 binding. Nuclear [125I]T3 binding was
measured in cardiomyocytes cultured at a density of 106
cells/well in 24-well culture dishes (10). Cells were preincu-
bated for 30 min at 37°C with 0.5 ml of medium without or
with 10 mM verapamil or nifedipine and incubated for 120
min at 37°C with 0.5 ml of medium with the same additions
plus [125I]T3 (200,000 cpm, 100 pM) without or with 10 mM
unlabeled T3. After incubation, cells were washed once with
2 ml of ice-cold saline. The cells were scraped from the wells
with a rubber policeman in 1 ml of PBS (on ice), and the wells
were washed with 0.5 ml of PBS. These two aliquots were
combined and centrifuged (300 g, 4°C, 7 min), and the cell
pellet was counted (30 s) and solubilized in 1 ml of PBS
containing 0.5% Triton X-100. After 2 min of continuous
vortexing, nuclei were spun down (900 g, 4°C, 5 min) and
washed once with 1 ml of PBS containing 0.5% Triton X-100.
The nuclear pellets were counted for 5 min and frozen for
DNA determination.
Dilution of Ca21 channel blockers. Stock solutions of vera-
pamil and nifedipine (10 mM) were prepared in dimethylsulf-
oxide (DMSO) and further diluted in DMSO to obtain 1 and
0.1 mM. These solutions were diluted 100-fold in incubation
medium to achieve final concentrations of 100, 10, and 1 mM
verapamil or nifedipine. Diltiazem was dissolved in H2O and
diluted similarly. Control incubations contained 1% DMSO
for verapamil or nifedipine.
Free T3 and T4 concentration. Calculation of the free T3
and T4 concentration was based on determinations of the free
fractions by equilibrium dialysis (30). Neither the free T3 nor
the free T4 fraction was altered by the presence of 1% DMSO.
ATP, DNA, and protein determinations. The cellular ATP
content was determined in 0.2 M perchloric acid extracts
with the AEC kit (Lumac, Landgraaf, The Netherlands).
DNA content was determined using a fluorometric method
(8). The cellular protein content was determined with a
protein assay kit (Bio-Rad, Munich, Germany). When cells
were plated at a density of 5 3 105 cells/well, protein content
after culture amounted to ;0.1 mg/well.
Materials. All reagents used for cell isolation and cell
culture were obtained from GIBCO Europe (Breda, The
Netherlands), with the exception of trypsin and deoxyribonu-
clease (Boehringer, Mannheim, Germany). Culture dishes
(48 and 24 wells) were obtained from Costar (Cambridge,
MA). Iodothyronines were obtained from Henning Berlin
(Berlin, Germany). BSA (fraction V), diltiazem, nifedipine,
and verapamil were purchased from Sigma Chemical (St.
Louis, MO), DMSO and Tris from Merck (Darmstadt, Ger-
many), 39-[125I]T3 (3,070 mCi/mg) and 39,59-[125I]T4 (1,500
mCi/mg) from Amersham International (Aylesbury, UK), and
Sephadex LH-20 from Pharmacia (Uppsala, Sweden). All
other reagents were of the highest purity available.
Validation of culture and washing procedure. Although
culture of cardiomyocytes in the presence of serum might
result in proliferation of fibroblasts that also show active
uptake of [125I]T3 and [125I]T4 (7), it has previously been
shown that uptake of [125I]T3 and [125I]T4 was comparable in
cardiomyocytes cultured in the absence and presence of se-
rum (10). In the present study, this was repeated measuring
[125I]T3 uptake in cells cultured for 5 days in the presence of
10% serum or 0.5% BSA or without any additions. The most
regular and synchronous contractile activity over the whole
well was observed in the serum-cultured cells, while the cells
cultured in the other conditions presented irregular contrac-
tions. Values for [125I]T3 uptake differed ,15% between the
three conditions. Moreover, when the 5-min [125I]T3 uptake
was compared in cardiomyocytes and fibroblasts in three
independent experiments and expressed as percent dose per
H1986 CA21 BLOCKERS AND CARDIAC THYROID HORMONE UPTAKE
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microgram of protein, the following data were obtained:
0.066 6 0.004 (n 5 3) and 0.006 6 0.001 (n 5 3) for cardio-
myocytes and fibroblasts, respectively, i.e., a 10-fold differ-
ence (S. M. van der Heide, unpublished results).
Sufficiency of the washing procedure after incubation was
checked by a direct comparison of washing with saline alone
and washing with saline containing 0.5% BSA. The 15-min
uptakes of [125I]T3 and [125I]T4, expressed as percentage of
the dose, were 0.60 6 0.02 (n 5 3) and 0.13 6 0.01 (n 5 3),
respectively, with the usual washing procedure. With 0.5%
BSA in the saline solution, these values amounted to 0.52 6
0.04 (n 5 3) and 0.11 6 0.01 (n 5 3), respectively.
Calculations and statistics. On the basis of the measure-
ments of the free hormone fractions, the chemical concentra-
tion of the hormones in the incubation medium (100 and 350
pM for [125I]T3 and [125I]T4, respectively), and the incubation
volume, the counts per minute were converted to femtomoles
per picomolar free hormone.
The statistical significance of any of the observed effects
was evaluated by Student’s t-test or by one-way analysis of
variance and Duncan’s test for multiple comparisons. P ,
0.05 was regarded as statistically significant.
RESULTS
Free T3 and T4 fraction. The free T3 fraction in
medium with 0.5% BSA was ;4%, similar to the free
T4 fraction in medium with 0.1% BSA. Both were
unaffected by the presence of 1% DMSO. The free T3
and T4 fractions showed no significant changes in the
presence of 1–100 mM verapamil, nifedipine, or dilti-
azem. Similarly, the free T3 fraction was unchanged by
20 mM K1 or Ca21-free medium (data not shown).
Time course of [125]T3 uptake and nuclear [125]T3
binding. Figure 1 shows the time course of [125I]T3
uptake at 15 min, 1 h, and 4 h of incubation expressed
as femtomoles per picomolar free T3. [125I]T3 uptake
was also measured in the presence of 10 mM verapamil,
nifedipine, or diltiazem after preincubation for 30 min
with these compounds. The uptake curve for [125I]T3
increased up to 4 h of incubation. Under control condi-
tions, [125I]T3 uptake at 15 min, 1 h, and 4 h was
0.091 6 0.004 (n 5 12), 0.246 6 0.016 (n 5 6), and
0.399 6 0.030 (n 5 6) fmol/pM free T3, respectively.
After 15 min, 1 h, and 4 h of incubation, [125I]T3 uptake
was inhibited by 44% (n 5 9, P , 0.05), 46% (n 5 5, P ,
0.05), and 25% (n 5 6, P , 0.05) in the presence of 10
mM verapamil and by 44% (n 5 9, P , 0.05), 56% (n 5
6, P , 0.05), and 38% (n 5 6, P , 0.05) in the presence
of 10 mM nifedipine. In the presence of 10 mM dilti-
azem, [125I]T3 uptake after 1 h was reduced by 20%
(n 5 6, P , 0.05) but showed no significant change
after 15 min or 4 h of incubation.
It is important to note that the relative decline in
[125I]T3 uptake after 4 h of incubation in the presence
of 10 mM of the Ca21 channel blockers was less than
that observed after 15 min or 1 h for verapamil and for
nifedipine. This might imply that the major inhibitory
effect of verapamil and nifedipine occurred at the level
of the cardiomyocyte plasma membrane. Consequently,
the amount of [125I]T3 bound to the nuclei should be
proportionally decreased.
This hypothesis was tested by incubating the cells
for 2 h with [125I]T3 and verapamil or nifedipine, the
most potent inhibitors of T3 transport, isolating the
nuclei, and determining DNA content. The results in
Table 1 show that 10 mM unlabeled T3, verapamil, or
nifedipine equally reduced cellular [125I]T3 uptake by
;40%. This was associated with a reduction of nuclear
[125I]T3 binding by 80% in the presence of 10 mM
unlabeled T3 and 44% in the presence of 10 mM vera-
pamil or nifedipine. Consequently, the ratio of nuclear
to cellular [125I]T3 uptake was 5% for cardiomyocytes
incubated with unlabeled T3 but was similar to control
values (;15%) for cardiomyocytes incubated with ve-
rapamil or nifedipine. The DNA content of all nuclear
pellets was the same.
Plasma membrane uptake of [125I]T3 and [125I]T4.
Uptake of [125I]T3 and [125I]T4 at the level of the cardio-
myocyte plasma membrane was evaluated during initial
uptake at 15 min of incubation. Under control conditions,
the uptake of [125I]T3, expressed as femtomoles per pico-
molar free hormone, amounted to 0.124 6 0.013 (n 5 6),
while that of [125I]T4 was 0.032 6 0.003 (n 5 12), a
fourfold difference (P , 0.05) as previously described (10).
Because verapamil and nifedipine were dissolved in
DMSO, 1% DMSO was added to the control incubations.
With 1% DMSO, the 15-min uptake of [125I]T3 was
0.110 6 0.010 (n 5 17) fmol/pM free T3 and that of
[125I]T4 was 0.036 6 0.005 (n 5 19) fmol/pM free T4, i.e.,
not different from the controls without DMSO (see
above).
Figure 2 shows the effect of preincubation and incu-
bation with 1–100 mM of verapamil, nifedipine, or
diltiazem on the uptake of [125I]T3. [125I]T3 uptake
decreased to 13% of control value (n 5 5, P , 0.05) with
Fig. 1. Time course of uptake of [125I]triiodothyronine (T3) in cul-
tured cardiomyocytes. Cardiomyocytes from 2-day-old rats were cul-
tured at a density of ;5 3 105 cells/well for 5 days in medium with
5% horse serum-5% FCS. Uptake of [125I]T3 (1 3 105 cpm; 100 pM)
was measured in medium with 0.5% BSA. Experiments were per-
formed at 37°C with 30 min of preincubation and incubation times
ranging from 15 min to 4 h in absence (control) or presence of 10 mM
verapamil (Ver), nifedipine (Nif), or diltiazem (Dil). Values are
means 6 SE of triplicate observations from 2 experiments. *P , 0.05
vs. control.
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100 mM verapamil (Fig. 2A). With nifedipine, identical
results were found (Fig. 2B). Although uptake of
[125I]T3 was slightly increased to 133% (n 5 6, not
significant) in the presence of 1 mM diltiazem, it was
59% (n 5 12, P , 0.05) and 75% (n 5 6, not significant)
of control with 10 and 100 mM diltiazem, respectively
(Fig. 2C).
The effects of preincubation and incubation with 1,
10, or 100 mM verapamil, nifedipine, and diltiazem on
the uptake of [125I]T4 are shown in Fig. 3. With vera-
pamil, uptake of [125I]T4 was reduced only at the high-
est concentration (Fig. 3A). With nifedipine, [125I]T4
uptake remained at control levels (Fig. 3B). Finally,
diltiazem inhibited uptake of [125I]T4 by ;45% inde-
pendent of the concentration (Fig. 3C).
ATP content. The effects of the Ca21 channel block-
ers on the ATP content of the cardiomyocytes were
investigated in two independent experiments. Com-
pared with the H2O controls (100.0 6 6.1%, n 5 6),
diltiazem (10 mM) did not alter the ATP content
(104.8 6 2.0%, n 5 6), nor did 1% DMSO (81.2 6
3.2%, n 5 6), 10 mM verapamil in 1% DMSO (78.8 6
8.3%, n 5 6), or 10 mM nifedipine in 1% DMSO
(95.2 6 5.3%, n 5 6).
Effects of 20 mM K1 and low Ca21 on [125I]T3 uptake.
Effects of the Ca21 channel blockers on [125I]T3 uptake
could be secondary to their inhibitory effect on Ca21
influx into the cardiomyocyte or to interference of the
Ca21 channel blockers with the T3 transport system.
To discriminate between these two possibilities,
[125I]T3 uptake was measured under conditions known
to increase (20 mM K1) or reduce (low Ca21) the Ca21
concentration in the cardiomyocyte (16, 34). In skeletal
muscle, we have demonstrated that the increase in
intracellular Ca21 by 20 mM K1 results from stimula-
tion of the Ca21 influx that can be prevented by Ca21
channel blockers (9).
Because the concentration of cations cannot be
changed in incubation medium based on DMEM-M199,
these experiments were carried out in KR buffer,
where Na1 was partly replaced by K1 or Ca21 was
omitted. The results are shown in Fig. 4. In normal KR
buffer, [125I]T3 uptake was 0.210 6 0.004 fmol/pM free
T3 (n 5 23), i.e., almost twice the value measured in
DMEM-M199 (compare with Fig. 2). As shown in Fig.
4, 20 mM K1 neither affected the uptake of [125I]T3 nor
altered the inhibitory effects of 10 mM verapamil and
nifedipine on [125I]T3 uptake. Furthermore, the effects
of verapamil, nifedipine, and diltiazem were identical
in KR buffer (Fig. 4) and DMEM-M199 (Fig. 2). In KR
buffer without Ca21, uptake of [125I]T3 was 113 6 7% of
the control uptake (n 5 9, not significant; not shown).
DISCUSSION
The profound influence of thyroid hormone on heart
function is well known (23, 31). Most of the effects of
thyroid hormone on heart require transport of T3 or T4
across the plasma membrane, although acute cellular
actions at the plasma membrane may be important as
well, in particular in heart (6, 12, 15, 27, 35). In
neonatal rat cardiomyocytes, a carrier-mediated up-
take mechanism for T3 similar to that in skeletal mus-
cle (24) has been demonstrated (10). In myoblasts of
the L6 cell line as well as in Hep G2 cells, Ca21 channel
blockers were found to inhibit T3 uptake (26, 32). In rat
cardiac ventriculocytes, 100 mM verapamil was also
found to reduce the efflux of T3 (25).
Our results show that representatives from two
different classes of organic Ca21 channel blockers,
i.e., verapamil and nifedipine, reduced the uptake of
[125I]T3 in cardiomyocytes in a dose-dependent fashion,
whereas they had a less pronounced effect on the up-
take of [125I]T4. Diltiazem, on the other hand, reduced
neither T3 nor T4 uptake in a dose-dependent way.
Only at a diltiazem concentration of 10 mM was a
minor reduction of T3 uptake seen, while T4 uptake
was inhibited to the same extent at 1, 10, or 100 mM
diltiazem. The relative potency for inhibition of T3
uptake in cardiomyocytes, i.e., nifedipine . vera-
pamil . diltiazem, is consistent with their relative
potency for inhibition of myocardial contractile force
(29). Also qualitatively, the effects of nifedipine and
verapamil on myocardial contractile function are dif-
ferent from those of diltiazem (3). It is interesting to
note that 10 nM–10 mM nifedipine and verapamil
inhibited the acute T3-induced increase in cardiac ino-
tropic activity of the perfused rat heart in a time- and
dose-related fashion (27). This study showed that the
acute effect of T3 on the heart is Ca21 dependent. The
results of our experiments as well as those of Topliss et
al. (32) in isolated cells, however, suggest that the
effect of the Ca21 channel blockers on T3 uptake is not
Ca21 dependent (see below). This discrepancy can be
Table 1. Effects of unlabeled T3, verapamil, and nifedipine on cellular and nuclear [125I]T3 activity, the ratio
of nuclear to cellular [125I]T3 uptake, and DNA content of the nuclear pellet
Experimental Conditions Cell Pellet (A) Nuclear Pellet (B) (B/A)* 100% DNA Content, mg
Controls 2.8460.31 0.4360.09 15.061.8 1.3860.23
T3 (10 mM) 1.7860.14* 0.0960.01* 5.160.4* 1.5560.06
Verapamil (10 mM) 1.6960.16* 0.2460.05* 14.162.1 1.3960.15
Nifedipine (10 mM) 1.7060.27* 0.2460.01* 14.762.5 1.6160.12
Values are means 6 SE of triplicate observations of a representative experiment. Cardiomyocytes were prepared from 2-day-old rats and
cultured for 1 day in 24-well dishes in DMEM-M199-5% FCS-5% horse serum at a density of ;106 cells/well. After 1 day, culture medium
was changed, and culture was continued for 4 days. Cells were incubated at 37°C for 2 h with [125I]triiodothyronine (T3, 200,000 cpm) in
medium with 0.5% BSA. Cells were scraped from the wells in PBS and centrifuged, and the cell pellet was counted. The nuclear pellet was
obtained after treatment with Triton X-100. *P , 0.05 vs. controls.
H1988 CA21 BLOCKERS AND CARDIAC THYROID HORMONE UPTAKE
AJP-Heart Circ Physiol • VOL 281 • NOVEMBER 2001 • www.ajpheart.org
 o
n
 N
ovem
ber 20, 2006 
ajpheart.physiology.org
D
ow
nloaded from
 
understood with the assumption that the Ca21-depen-
dent inhibition of inotropy relates to a plasma mem-
brane-mediated nongenomic effect of T3 (27), while
inhibition of T3 uptake by Ca21 channel blockers will
result in a reduction of intracellular T3 and, thus,
nuclear T3 binding with potentially a subsequent re-
duction of the genomic effect.
T3 uptake studies with rat L6 myoblasts showed
inhibitory effects of Ca21 channel blockers in the fol-
lowing order, nifedipine . diltiazem . verapamil, at
1–100 mM in protein-free medium (32). As in cardio-
myocytes, T3 is actively taken up in skeletal muscle by
an energy-dependent process (24). However, skeletal
muscle Ca21 channels are not identical to those of
cardiac muscle (19). Moreover, despite the fact that the
density of Ca21 channel blocker-binding sites is ;100-
fold greater in skeletal muscle than in cardiac muscle
(19), skeletal muscle is relatively insensitive to Ca21
channel blockers (11, 19).
Previously, it was demonstrated by fluorometric
(fura 2-AM) measurements of the intracellular free
Ca21 concentration that incubation of neonatal rat
cardiomyocytes with low Ca21 and high K1 decreased
and increased, respectively, the level of intracellular
Fig. 2. Effects of Ca21 channel blockers on the 15-min uptake of
[125I]T3. Cardiomyocytes from 2-day-old rats were isolated and cul-
tured as described in Fig. 1 legend. Uptake of [125I]T3 (1 3 105 cpm;
100 pM) was measured as described in Fig. 1 legend, with 30 min of
preincubation and 15 min of incubation in absence or presence of 1,
10, or 100 mM verapamil (A), nifedipine (B), or diltiazem (C). Values
are means 6 SE of triplicate observations from 2–5 experiments.
*P , 0.05 vs. control.
Fig. 3. Effects of Ca21 channel blockers on the 15-min uptake of
[125I]thyroxine (T4). Cardiomyocytes from 2-day-old rats were iso-
lated and cultured as described in Fig. 1 legend. Uptake of [125I]T4
(2 3 105 cpm; 350 pM) was measured as described in Fig. 2 legend,
in absence or presence of 1, 10, or 100 mM verapamil (A), nifedipine
(B), or diltiazem (C) in medium with 0.1% BSA. Values are means 6
SE of triplicate observations from 3–5 experiments. *P , 0.05 vs.
control.
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free Ca21 (34). Similar to results obtained in L6 myo-
blasts (32), our experiments performed in low-Ca21
medium or in medium containing 20 mM K1 did not
reveal any change in T3 uptake. Furthermore, the
effect of the Ca21 channel blockers on [125I]T3 uptake
was not altered in the presence of 20 mM K1. There-
fore, from the present results it seems that inhibition
or stimulation of the Ca21 flux itself (9) does not pro-
vide the basis for the inhibitory effects of the Ca21
channel blockers on [125I]T3 uptake. This leaves as
alternative possibilities: 1) a structural similarity be-
tween the Ca21 channel blocker-binding site and a
thyroid hormone transporter binding site or 2) a phys-
icochemical similarity between the Ca21 channel
blockers and T3 itself. Finally, the question has been
addressed as to whether the inhibitory effects of Ca21
channel blockers on T3 uptake may be mediated by
their calmodulin antagonism (32). Because the calmod-
ulin antagonistic activity of most Ca21 channel block-
ers is very low (19), we have not further investigated
this possibility.
When 10 mM unlabeled T3 was added to incubations
of cardiomyocytes with [125I]T3, the inhibitory effect
was greater after 2–4 h than after 15 min of incubation
(10). Moreover, the reduction of nuclear [125I]T3 bind-
ing was almost complete, while that of cellular [125I]T3
uptake was ;40% (10) (this study). The inhibitory
effect of the Ca21 channel blockers was greater after 15
min than after 4 h of incubation, while the reduction of
nuclear [125I]T3 binding by nifedipine and verapamil
was proportional to the reduction of cellular [125I]T3
uptake. This suggests that Ca21 channel blockers do
not directly interfere with nuclear T3 binding and that
the inhibition of [125I]T3 uptake by Ca21 channel block-
ers primarily occurs at the level of the plasma mem-
brane. The data also show that the effect of Ca21
channel blockers on [125I]T3 uptake is not associated
with changes in cellular ATP. This is important be-
cause the T3 uptake mechanism in the cardiomyocyte
is largely dependent on cellular ATP (10). Our finding
of normal ATP contents at Ca21 channel blocker con-
centrations of 10 mM excludes a possible effect of any of
the compounds via ATP.
Our preparation of cardiomyocytes cultured on cul-
ture dishes is not suited to study qualitatively or quan-
titatively the effects of short-term interventions on
contractility of the cardiomyoctes. However, it is an
important issue to address the effect of contractility
per se on T3 uptake. It has been shown that contrac-
tions of cardiomyocytes were smaller in medium with
low Ca21 (16). Furthermore, exposure to 50 mM KCl
(18) and 10 mM verapamil (4, 18) for 2–3 days resulted
in contraction-arrested cells. Also, short-term incuba-
tion (20 min) with low Ca21, 50 mM KCl, or 1 mM
nifedipine completely blocked contractility of the car-
diomyocytes (34). However, the study by Muller et al.
(18) demonstrated that the effect of 5 nM T3 on the
mRNA and the protein levels of the SERCA2 enzyme
was identical in contracting and contraction-arrested
cardiomyoctes, suggesting that T3 can enter the cells
and interact with the nucleus, independently of their
contractile status. This confirmed the in vivo observa-
tion of Ojamaa et al. (21) that thyroid hormone could
alter the expression of SERCA2 independently of the
thyroid hormone-induced hemodynamic loading of the
heart.
In human serum, the greater part of Ca21 channel
blockers is bound to protein: ;90, 95, and 85% for
verapamil, nifedipine, and diltiazem, respectively (29).
Although the therapeutic levels of free Ca21 channel
blockers in human serum are ;0.01 mM, in vitro effects
are generally observed at free concentrations between
0.01 and 100 mM (29). Therefore, our experiments were
performed using concentrations of 1–100 mM with 0.5
or 0.1% BSA in the medium, thus achieving free con-
centrations ranging from close to therapeutic levels to
the concentrations used in in vitro experiments.
Whereas the free concentration of the Ca21 channel
blockers in experiments with [125I]T4 was higher be-
cause of the lower BSA concentration in the medium,
the effects of nifedipine and verapamil on [125I]T4 up-
take were smaller than those on [125I]T3 uptake. In
view of the observations in our previous study (10) that
T4 entry into the cardiomyocyte is low and probably not
mediated by an active transport mechanism, the ef-
fects of diltiazem or a high concentration of verapamil
on T4 uptake may be nonspecific and not indicative for
inhibition of an active transport mechanism.
In summary, our study describes significant inhibi-
tory effects of Ca21 channel blockers on the uptake of
T3 in cardiomyocytes and a less clear effect on the
uptake of T4. It has been shown that neither verapamil
nor nifedipine directly affected the serum levels of free
T3, T4, or thyroid-stimulating hormone (37). Our find-
ings suggest that, in addition to the reduction of Ca21
entry into the cardiomyocyte, which suppresses myo-
cardial contractile force and cardiac energy consump-
tion (3, 5), Ca21 channel blockers will reduce the intra-
cellular T3 concentration in the cardiomyocyte. This
Fig. 4. Effects of 20 mM K1 on [125I]T3 uptake in absence or presence
of Ca21 channel blockers. Cardiomyocytes from 2-day-old rats were
isolated and cultured as described in Fig. 1 legend. Uptake of [125I]T3
(1 3 105 cpm; 100 pM) was measured as described in Fig. 2 legend in
Krebs-Ringer buffer with 0.5% BSA in absence or presence of 10 mM
verapamil, nifedipine, or diltiazem with 5.6 or 20 mM K1 (K1).
Values are means 6 SE of triplicate observations from 3 experi-
ments. *P , 0.05 vs. control.
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will contribute to a decrease in cardiac output and
energy turnover and may thus help prevent myocardial
ischemia. On the other hand, T3 also acts on the
smooth muscle cells, causing vascular relaxation, lead-
ing to a decrease in systemic vascular resistance (20).
It is therefore important to realize that a Ca21 channel
antagonist to be used in a clinical setting as a supple-
ment to control cardiac thyrotoxic symptoms preferen-
tially should have a greater effect on Ca21 influx in
heart than in smooth muscle cells.
M. E. Everts held a fellowship of the Royal Netherlands Academy
of Arts and Sciences. The study was supported by Netherlands Heart
Foundation Grant 96.175.
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